Cognition Therapeutics, Inc.
$1.02
-0.04 (-3.77%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +11.4%
- 3 Months
- -13.6%
- YTD
- -24.4%
- 1 Year
- -66.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 107.2%
- Largest decline max drawdown, since Aug 2025
- -81.3%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.45
Own CGTX?
See how CGTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.